tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market

Keymed Biosciences, Inc. (2162) Revenue

Compare
1 Followers

Keymed Biosciences, Inc. Revenue

Keymed Biosciences, Inc. had a revenue of 498.75M in the quarter ending Jun 30, 2025, with 33.56%. This bring the company's revenue in the last twelve months to 872.19M, Decreased 103.72%. In the fiscal year ending Dec 31, 2024, Keymed Biosciences, Inc. had annual revenue of 428.12M with 20.91% growth.
Revenue (ttm)
872.19M
Revenue Growth
964.40%
P/S Ratio
36.63
Revenue/Employee
HK$340,321
Employees
1,258
Market Cap
HK$15.68B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
428.12M74.03M+120.91%
Dec 31, 2023
354.10M254.03M+353.87%
Dec 31, 2022
100.06M-10.21M+90.74%
Dec 31, 2021
110.27M-11,026,900,000.00%
Dec 31, 2020
Dec 31, 2019